Compare INFU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | TMCI |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.6M | 292.0M |
| IPO Year | 2005 | 2021 |
| Metric | INFU | TMCI |
|---|---|---|
| Price | $14.09 | $4.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $18.50 | $6.17 |
| AVG Volume (30 Days) | 136.9K | ★ 307.8K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | $143,436,000.00 | ★ $212,690,000.00 |
| Revenue This Year | $1.42 | N/A |
| Revenue Next Year | $5.89 | $6.15 |
| P/E Ratio | $41.63 | ★ N/A |
| Revenue Growth | ★ 6.36 | 1.59 |
| 52 Week Low | $7.29 | $1.17 |
| 52 Week High | $15.47 | $5.44 |
| Indicator | INFU | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 47.52 |
| Support Level | $11.97 | $3.96 |
| Resistance Level | $14.64 | $4.95 |
| Average True Range (ATR) | 0.72 | 0.52 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 57.26 | 47.77 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.